High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Trauma

• Publication date

  1998-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00005373-199802000-00023PMID 9498512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The anaemia of chronic disorders. A bag of unsolved questions.

  2009cited by this paper
• Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit.

  1996cited by this paper
• Hyperdynamic sepsis depresses circulatory compensation to normovolemic anemia in conscious rats.

  1996cited by this paper
• Translational enhancement of H-ferritin mRNA by interleukin-1 beta acts through 5' leader sequences distinct from the iron responsive element

  1994cited by this paper
• Pathogenesis and Treatment of the Anemia of Chronic Disease

  1994cited by this paper
• Effects of accidental trauma on cytokine and endotoxin production

  1993cited by this paper
• Effects of accidental trauma on cytokine and endotoxin production.

  1993cited by this paper
• Effect of inflammatory cytokines on hypoxia-induced erythropoietin production.

  1992cited by this paper
• Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer.

  1992cited by this paper
• EFFECT OF INFLAMMATORY CYTOKINES ON HYPOXIA-INDUCED ERYTHROPOIETIN PRODUCTION

  1992cited by this paper
• Progress in understanding the pathogenesis of the anemia of chronic disease.

  1992cited by this paper
• Inhibition of human erythroid colony‐forming units by interleukin‐1 is mediated by gamma interferon

  1992cited by this paper
• Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys.

  1992cited by this paper
• Anemia of chronic inflammatory arthritides: treatment with recombinant human erythropoietin.

  1991cited by this paper
• Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin.

  1991cited by this paper
• Immune activation and the anaemia associated with chronic inflammatory disorders

  1991cited by this paper
• Transforming growth factor-beta in rheumatoid arthritis.

  1990cited by this paper
• Recombinant human erythropoietin activates a broad spectrum of progenitor cells.

  1990cited by this paper
• In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO).

  1990cited by this paper
• Recombinant human erythropoietin for patients with AIDS treated with zidovudine.

  1990cited by this paper
• Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration.

  1990cited by this paper
• Anaemia of chronic disease in rheumatoid arthritis. Raised serum interleukin-6 (IL-6) levels and effects of IL-6 and anti-IL-6 on in vitro erythropoiesis.

  1990cited by this paper
• Erythropoietin treatment of anemia associated with multiple myeloma.

  1990cited by this paper
• Correlation between neopterin, interferon‐gamma and haemoglobin in patients with haematological disorders

  1990cited by this paper
• Inhibition of human colony-forming-unit erythroid by tumor necrosis factor requires accessory cells.

  1990cited by this paper
• Transforming growth factor beta directly regulates primitive murine hematopoietic cell proliferation.

  1990cited by this paper
• Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis.

  1990cited by this paper
• Transforming Growth Factor‐β in Rheumatoid Arthritis

  1990cited by this paper
• Urinary Neopterin in Monoclonal Gammopathies

  1990cited by this paper
• In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets.

  1990cited by this paper
• A new scoring system for disease intensity in a surgical intensive care unit

  1989cited by this paper
• In vivo hematopoietic effects of recombinant interleukin-1 alpha in mice: stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppression of late-stage erythropoiesis, and reversal of erythroid suppression with erythropoietin.

  1989cited by this paper
• Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies.

  1989cited by this paper
• Transfusion and recipient immune function.

  1989cited by this paper
• Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro.

  1988cited by this paper
• Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis.

  1988cited by this paper
• Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides.

  1988cited by this paper
• Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients.

  1988cited by this paper
• Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells.

  1987cited by this paper
• Special report: transfusion risks.

  1987cited by this paper
• Blunted erythropoietin response to anaemia in rheumatoid arthritis

  1987cited by this paper
• Phase I study of recombinant tumor necrosis factor in cancer patients.

  1987cited by this paper
• Effects of recombinant human tumor necrosis factor (rhTNF) on normal human and mouse hemopoietic progenitor cells.

  1987cited by this paper
• INCREASED RATIO OF GRANULOCYTE/MACROPHAGE PROGENITOR CELLS (CFU‐GM) TO MULTILINEAGE PROGENITOR CELLS (CFU‐mix) IN THE PERIPHERAL BLOOD FROM PATIENTS WITH ACUTE NON‐LYMPHOBLASTIC LEUKAEMIA IN VERY EARLY REMISSION

  1986cited by this paper
• [The Hannover Intensive Score (HIS) as a new classification system in the follow-up and prognostic evaluation of intensive care patients].

  1986cited by this paper
• Phase I trial of recombinant interferon gamma in cancer patients.

  1986cited by this paper
• Studies of interferon as a regulator of hematopoietic cell proliferation.

  1985cited by this paper
• Suppression of normal human erythropoiesis by gamma interferon in vitro. Role of monocytes and T lymphocytes.

  1985cited by this paper
• APACHE II: A severity of disease classification system

  1985cited by this paper
• APACHE II: a severity of disease classification system.

  1985cited by this paper
• Giant lymph node hyperplasia (Castleman's disease) of the mesentery. Observations on the associated anemia.

  1984cited by this paper
• Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro.

  1984cited by this paper
• The anemia of chronic disease.

  1983cited by this paper
• Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.

  1983cited by this paper
• The growth of large megakaryocyte colonies from human bone marrow

  1982cited by this paper
• HEPATITIS B NOT TRANSMISSIBLE VIA FÆCAL-ORAL ROUTE

  1975cited by this paper
• The anemia of chronic disorders.

  1966cited by this paper

• Anaemia in Surgical Sepsis and Stress: The Roles of Erythropoietin, Iron and Steroids

  2019cites this paper
• Safety and efficacy of erythropoiesis-stimulating agents in critically ill patients admitted to the intensive care unit: a systematic review and meta-analysis

  2019cites this paper
• Jehovah’s Witness and the Bleeding Surgical Patient

  2017cites this paper
• Harms of off-label erythropoiesis-stimulating agents for critically ill people.

  2017cites this paper
• Ceruloplasmin and Hypoferremia: Studies in Burn and Non-Burn Trauma Patients

  2015cites this paper
• Blood transfusion in surgery

  2014cites this paper
• Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis

  2013cites this paper
• Anémie de réanimation : physiopathologie et prise en charge

  2013cites this paper
• Anemia and transfusion in critically ill pediatric patients: a review of etiology, management, and outcomes.

  2013cites this paper
• Impact of Erythropoietin on Intensive Care Unit Patients

  2013cites this paper
• The use of erythropoiesis-stimulating agents in the intensive care unit.

  2012cites this paper
• Anemia Therapy I: Erythropoiesis‐Stimulating Agents

  2012cites this paper
• Lipopolysaccharide interference in erythropoiesis in mice

  2012cites this paper
• Anemia and Red Blood Cell Transfusion in Critically Ill Patients

  2011cites this paper
• Transfusion protocol in trauma

  2011cites this paper
• Bench to bedside: A role for erythropoietin in sepsis

  2010cites this paper
• Treatment of Anemia

  2010cites this paper
• Revisión ¿ Eritropoyetina humana recombinante , ¿ Una alternativa válida para el tratamiento de la anemia del paciente crı́tico ?

  2009cites this paper
• Lipopolysaccharide Evokes Resistance to Erythropoiesis Induced by the Long-Acting Erythropoietin Analogue Darbepoetin Alfa in Rats

  2009cites this paper
• Removal of erythropoietin from anaemia trauma practice guideline does not increase red blood cell transfusions and decreases hospital utilization costs.

  2009cites this paper
• [Is there still a role for recombinant erythropoietin in the management of anaemia of critical illness?].

  2009cites this paper
• What to do if no blood is available but the patient is bleeding?

  2008cites this paper
• Massive Transfusion and Control of Hemorrhage in the Trauma Patient

  2008cites this paper
• Management of hemorrhagic shock when blood is not an option.

  2008cites this paper
• Anemia and Blood Transfusion in the Critically Ill Patient

  2008cites this paper
• Anemia of Critical Illness

  2008cites this paper
• Anemia, Erythropoietin, and the Trauma Patient

  2008cites this paper
• WHEN TO USE IT AND HOW TO MINIMIZE IT

  2008cites this paper
• Anemia in the Critically Ill Patient

  2008cites this paper
• [Prevalence and treatment of anemia in critically ill patients].

  2007cites this paper
• Chapter 32 – Red Cell Transfusion in Perioperative and Critically Ill Patients

  2007cites this paper
• Erythropoietin improves skeletal muscle microcirculation and tissue bioenergetics in a mouse sepsis model

  2007cites this paper
• Prevalencia y tratamiento de la anemia en el paciente crítico

  2007cites this paper
• Anemia in critical care patients: incidence, etiology, impact, management, and use of treatment guidelines and protocols.

  2007cites this paper
• Blood Management: A Primer for Clinicians

  2007cites this paper
• Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials

  2007influential citation
• Alternatives to blood product transfusion in the critically ill: Erythropoietin

  2006influential citation
• The role of erythropoietin therapy in the critically ill.

  2006cites this paper
• Erythropoiesis in multiply injured patients.

  2006cites this paper
• CRITICAL CARE ISSUES FOR THE NEPHROLOGIST: Anemia and Red Blood Cell Transfusion in the Critically Ill

  2006cites this paper
• Diagnosis and management of iron-related anemias in critical illness

  2006cites this paper
• Erythropoietic Response to Two Epoetin alfa Regimens in Critically Ill Patients: A Pilot Study

  2006cites this paper
• Prospective randomized double-blind placebo controlled trial of recombinant human erythropoietin administration to reduce blood transfusions in anemic pediatric intensive care patients.

  2006cites this paper
• Clinical strategies in the medical care of Jehovah's Witnesses.

  2006cites this paper
• Can erythropoietin eradicate red cell transfusions in the critically ill?

  2006cites this paper
• L’anémie et sa compensation transfusionnelle en réanimation

  2006cites this paper
• CLINICAL STRATEGIES FOR MANAGING ACUTE GASTROINTESTINAL HEMORRHAGE AND ANEMIA WITHOUT BLOOD TRANSFUSION

  2006cites this paper
• Blood conservation in the critically ill patient.

  2005cites this paper
• Iron and the Risk of Infection

  2005cites this paper
• Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients.

  2005cites this paper
• Anemia in critically ill patients.

  2005cites this paper
• Erythropoietin in the critically ill: what is the evidence?

  2005cites this paper
• ANEMIA WITHOUT BLOOD TRANSFUSION IN SURGICAL PATIENTS* GENERAL NONBLOOD MANAGEMENT PRINCIPLES GENERAL THERAPEUTIC PRINCIPLES

  2005cites this paper
• Review Pathophysiology of intensive care unit-acquired anemia

  2004cites this paper
• Use of blood products in sepsis: An evidence-based review

  2004cites this paper
• Anemia and blood transfusion in the critically ill patient: role of erythropoietin

  2004cites this paper
• Managing Anemia in the Critically Ill Patient

  2004cites this paper
• Pathophysiology of intensive care unit-acquired anemia

  2004cites this paper
• Indications et limites de l'utilisation d'érythropoïétine recombinée en réanimation

  2004cites this paper
• Use of exogenous erythropoietin in critically ill patients

  2004influential citation
• Anemia in the critically ill.

  2004cites this paper
• [Indications and limits of recombinant human erythropoietin in intensive care unit].

  2004cites this paper
• Is there a place for epoetin alfa in managing anemia during critical illness?

  2004cites this paper
• Iron supplementation in the intensive care unit: when, how much, and by what route?

  2004cites this paper
• Erythropoietin in the critically ill

  2004cites this paper
• Use of Epoetin Alfa in Critically III Patients

  2004cites this paper
• Erythropoietin for Prevention and Treatment of Anemia in the Intensive Care Unit

  2004cites this paper
• Large volume polymerized haemoglobin solution in a Jehovah's Witness following abruptio placentae

  2004cites this paper
• Review Anemia and blood transfusion in the critically ill patient: role of

  2004cites this paper
• Blood transfusion in intensive care : artificial oxygen carriers , erythropoietin and iron , future issues

  2003influential citation
• Anemia, Blood Transfusion, and Erythropoietin in the Critically Ill

  2003cites this paper
• Transfusion practice in the critically ill

  2003cites this paper
• Substituts à l'hémoglobine, érythropoïétine et fer : quel avenir en réanimation ?

  2003influential citation
• Conférence du XXXIe congrès de la SRLF. Transfusion en réanimationOverview of transfusion practices in perioperative and critical care

  2003cites this paper
• Anemia and red cell transfusion in critically ill patients

  2003cites this paper
• Érythropoïétine en réanimation

  2003influential citation
• The hematologic system as a marker of organ dysfunction in sepsis.

  2003cites this paper
• Anemia: Critical Illness/Counseling/Fluoroquinolone Interactions: Absorption

  2003cites this paper
• Anemia in the intensive care unit.

  2003cites this paper
• Erythropoietin in the Critically Ill

  2003cites this paper
• Erythropoietin therapy in children with bronchiolitis and anemia*

  2003cites this paper
• Transfusionenréanimation Overview of transfusion practices in perioperative and critical care

  2003cites this paper
• Red blood cell physiology in critical illness

  2003cites this paper
• Mise au pointÉrythropoïétine en réanimationErythropoietine use in intensive care

  2003influential citation
• Combined blood substitute and erythropoietin therapy in a severely injured Jehovah's Witness.

  2002cites this paper
• CARING FOR THE CRITICALLY ILL PATIENT Anemia and Blood Transfusion in Critically Ill Patients

  2002cites this paper
• Anemia and Blood Transfusion in the Critically Ill: The Role of Erythropoietin

  2002cites this paper
• Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery.

  2002cites this paper
• Anemia and Blood Transfusion in the Critically Ill: Role of Erythropoietin

  2002cites this paper
• Blood Transfusion Issues in the Critically Ill

  2002cites this paper
• Blood substitute and erythropoietin therapy in a severely injured Jehovah's witness.

  2002cites this paper
• The Molecular Epidemiology of Malaria in Western Kenya

  2002cites this paper
• Anaemia of critical illness-- implications for understanding and treating rHuEPO resistance.

  2002cites this paper
• Anemia and blood transfusion in critically ill patients.

  2002cites this paper
• Profound bias in interferon-gamma and interleukin-6 allele frequencies in western Kenya, where severe malarial anemia is common in children.

  2002cites this paper
• Recombinant Human Erythropoietin Use in Intensive Care

  2002cites this paper
• The effects of iron deficiency on lymphocyte cytokine production and activation: preservation of hepatic iron but not at all cost

  2001cites this paper
• Acute event‐related anaemia

  2001cites this paper
• [Storage dependent effects on the oxygen tranport capacity of erythrocyte concentrates].

  2001cites this paper
• [Erythropoietin--an alternative to foreign blood transfusion].

  2001cites this paper